MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2019 International Congress

    Positive response to Botulinum Toxin injections in a patient with Painless Hand with Moving Fingers: A Case Report and Literature Review

    Z. Rosensweet, A. Persaud, E. Gaitour, N. Shneyder (Jacksonville, FL, USA)

    Objective: Objective: We present a rare case and literature review of Painless Hand with Moving Fingers (PHMF) that adequately responded to Onabotulinum toxin A (Botox)…
  • 2019 International Congress

    Classification of idiopathic cervical dystonia: an observational study

    P. Tater, N. Sarma, S. Pandey (New Delhi, India)

    Objective: The aim of our study was to classify patients with idiopathic cervical dystonia who had never been injected botulinum toxin. Background: Idiopathic cervical dystonia…
  • 2019 International Congress

    High Dose Botulinum Toxin Therapy: Safety, Benefit and Endurance of Efficacy

    S. Chiu, B. Patel, M. Burns, J. Legacy, A. Shukla, A. Ramirez-Zamora, W. Deeb, I. Malaty (Gainesville, FL, USA)

    Objective: To assess safety, therapeutic response and long-term benefit of higher dose Onabotulinum toxin A (OnaA). Background: Botulinum toxin therapy is a powerful tool for…
  • 2019 International Congress

    Effect of Botulinum Toxin Treatment on Cervical Dystonia

    S. Tomic, M. Tomasevic, D. Hardi, T. Gilman Kuric, Z. Popovic (Osijek, Croatia)

    Objective: To find out influence of botulinum toxin (BonT) treatment on improvement of motor symptoms and pain.To find out influence of botulinum toxin (BonT) treatment…
  • 2019 International Congress

    Botulinum toxin type A therapy in a movement disorders unit: a 23-year experience.

    M. Velez, C. Cosentino, L. Torres (Lima, Peru)

    Objective: To update the experience with botulinum toxin type A therapy at the Unidad de Movimientos Involuntarios (UMI) of Instituto Nacional de Ciencias Neurologicas (INCN)-Lima,…
  • 2019 International Congress

    Management of poor response to Botulinum toxin in cervical dystonia: a multicentre audit

    H. Tucker, F. Osei-Poku, D. Ashton, R. Lally, J. Alty, C. Kobylecki (Salford, United Kingdom)

    Objective: To audit the management of cervical dystonia patients with secondary poor responsiveness to BoNT in two regional U.K. neuroscience centres against the British Neurotoxin…
  • 2019 International Congress

    Effect of a Combined Treatment with Botulinum Toxin and Biofeedback Exercises in Pisa Syndrome

    A. Castagna, A. Crippa, D. Anastasi, M. Meloni, A. Montesano, A. Marzegan (Milano, Italy)

    Objective: To assess the efficacy of a combined botulinum neurotoxin (BoNT) treatment with biofeedback exercises in a single Parkinson Disease (PD) patient with Pisa Syndrome…
  • 2019 International Congress

    Tardive Cervical Dystonia: Treatment with Botulinum: Treatment with Botulinum Toxin Guided by Electromyography

    LFV. Vasconcellos, MS. Spitz, DN. Nassif, BRA. Andrade (Rio de Janeiro, Brazil)

    Objective: To describe the use of botulinum toxin in the treatment of tardive dystonia. Background: Tardive dystonia (TD) was recognized as a complication of dopamine…
  • 2019 International Congress

    Clinical Profile and Response to EMG-Guided Botulinum toxin (BTX) Injection in Writers’ Cramp (WC)- A Study of 25 Indian Patients

    P. Agarwal, P. Palekar (Mumbai, India)

    Objective: To study WC and its response to EMG-Guided BTX Background: Despite decades of use and popularity of BTX in WC, there is a paucity of…
  • 2019 International Congress

    Use of Chemodenervation for Secondary Limb Dystonia in Parkinson’s Disease: A Single Center Experience

    V. Veerappan, M. Brodsky (Portland, OR, USA)

    Objective: To describe characteristics of patients with secondary limb dystonia in Parkinson’s Disease, types of dystonia observed, and treatment/response with chemodenervation. Background: Dystonia can be…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley